News

Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update

CAPE CANAVERAL, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of…

1 year ago

Gracell Biotechnologies Wins Overall Immunology Solution of the Year by BioTech Breakthrough Awards Program

Third annual BioTech Breakthrough Award recognizes excellence in life science and biotechnology solutions, services and companies GC012F, a FasTCAR-enabled autologous…

1 year ago

Safety Shot is the Official Title Sponsor of Save our Musicians Foundation Special Night with Luke Bryan

Safety Shot, Inc. Luke Bryan Safety Shot drink samples to be given to concert-goersSafety Shot brand featured on ticketing page,…

1 year ago

Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023

WOODCLIFF LAKE, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced…

1 year ago

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2023 Financial Results on November 14, 2023

FREDERICK, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in…

1 year ago

Government Agencies Emphasize the Importance of Decentralized Methodologies for Future of Clinical Research

Decentralized Trials & Research Alliance brings together Global Leaders for its Annual Meeting SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE)…

1 year ago

Sofwave Medical Reports Third Quarter 2023 Financial Results and Business Highlights

- Third quarter revenue of $12.2M, +49% year-over-year growth- Third quarter pulse recurring revenue of $3.1M, +99% year-over-year growth- First nine…

1 year ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national…

1 year ago

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics,…

1 year ago

Organovo Highlights FXR314 Combination Therapy Potential and Plan

SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is…

1 year ago